Effects of endocrine disruptors on imprinted gene expression in the mouse embryo

Epigenetics

Volumn 6, Issue 7, 2011, Pages 937-950

  Kang, Eun Rim ^a   Iqbal, Khursheed ^a   Tran, Diana A ^a   Rivas, Guillermo E ^a   Singh, Purnima ^a   Pfeifer, Gerd P ^a   Szabó, Piroska E ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Bisphenol A; DEHP; Environment; Epigenetics; Genomic imprinting; Vinclozolin

Indexed keywords

BISPHENOL A BIS(2 HYDROXYPROPYL) ETHER DIMETHACRYLATE; ENDOCRINE DISRUPTOR; VINCLOZOLIN;

AMNION; ARTICLE; BODY COMPOSITION; EMBRYO (ANATOMY); EPIGENETICS; FEMALE; GENE EXPRESSION; GENETIC SUSCEPTIBILITY; GENOME IMPRINTING; HAPLOID SPORE; HEAD; HEART; INTESTINE; LIVER; LUNG; MOUSE; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; PLACENTA; PREGNANCY; RNA ISOLATION; STOMACH; YOLK SAC;

MUS;

EID: 79960138554     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.6.7.16067     Document Type: Article

References (72)

1. Anway MD, Cupp AS, Uzumcu M, Skinner MK. Epigenetic transgenerational actions of endocrine disruptors and male fertility. Science 2005; 308:1466-9.
2. Trubo R. Endocrine-disrupting chemicals probed as potential pathways to illness. JAMA 2005; 294:291-3.
3. Calafat AM, Kuklenyik Z, Reidy JA, Caudill SP, Ekong J, Needham LL. Urinary concentrations of bisphenol A and 4-nonylphenol in a human reference population. Environ Health Perspect 2005; 113:391-5.
4. vom Saal FS, Hughes C. An extensive new literature concerning low-dose effects of bisphenol A shows the need for a new risk assessment. Environ Health Perspect 2005; 113:926-33.
5. Takai Y, Tsutsumi O, Ikezuki Y, Kamei Y, Osuga Y, Yano T, et al. Preimplantation exposure to bisphenol A advances postnatal development. Reprod Toxicol 2001; 15:71-4.
6. Honma S, Suzuki A, Buchanan DL, Katsu Y, Watanabe H, Iguchi T. Low dose effect of in utero exposure to bisphenol A and diethylstilbestrol on female mouse reproduction. Reprod Toxicol 2002; 16:117-22.
7. Howdeshell KL, Hotchkiss AK, Thayer KA, Vandenbergh JG, vom Saal FS. Exposure to bisphenol A advances puberty. Nature 1999; 401:763-4.
8. Nagel SC, vom Saal FS, Thayer KA, Dhar MG, Boechler M, Welshons WV. Relative binding affinityserum modified access (RBA-SMA) assay predicts the relative in vivo bioactivity of the xenoestrogens bisphenol A and octylphenol. Environ Health Perspect 1997; 105:70-6.
9. Timms BG, Howdeshell KL, Barton L, Bradley S, Richter CA, vom Saal FS. Estrogenic chemicals in plastic and oral contraceptives disrupt development of the fetal mouse prostate and urethra. Proc Natl Acad Sci USA 2005; 102:7014-9.
10. vom Saal FS, Cooke PS, Buchanan DL, Palanza P, Thayer KA, Nagel SC, et al. A physiologically based approach to the study of bisphenol A and other estrogenic chemicals on the size of reproductive organs, daily sperm production and behavior. Toxicol Ind Health 1998; 14:239-60.
11. Markey CM, Luque EH, Munoz De Toro M, Sonnenschein C, Soto AM. In utero exposure to bisphenol A alters the development and tissue organization of the mouse mammary gland. Biol Reprod 2001; 65:1215-23.
12. Schonfelder G, Wittfoht W, Hopp H, Talsness CE, Paul M, Chahoud I. Parent bisphenol A accumulation in the human maternal-fetal-placental unit. Environ Health Perspect 2002; 110:703-7.
13. Wozniak AL, Bulayeva NN, Watson CS. Xenoestrogens at picomolar to nanomolar concentrations trigger membrane estrogen receptor-alpha-mediated Ca2+ fluxes and prolactin release in GH3/B6 pituitary tumor cells. Environ Health Perspect 2005; 113:431-9.
14. Zoeller RT, Bansal R, Parris C. Bisphenol-A, an environmental contaminant that acts as a thyroid hormone receptor antagonist in vitro, increases serum thyroxine and alters RC3/neurogranin expression in the developingrat brain. Endocrinology 2005; 146:607-12.
15. Paris F, Balaguer P, Terouanne B, Servant N, Lacoste C, Cravedi JP, et al. Phenylphenols, biphenols, bisphenol- A and 4-tert-octylphenol exhibit alpha and beta estrogen activities and antiandrogen activity in reporter cell lines. Mol Cell Endocrinol 2002; 193:43-9.
16. Welshons WV, Thayer KA, Judy BM, Taylor JA, Curran EM, vom Saal FS. Large effects from small exposures. I. Mechanisms for endocrine-disrupting chemicals with estrogenic activity. Environ Health Perspect 2003; 111:994-1006.
17. Blount BC, Silva MJ, Caudill SP, Needham LL, Pirkle JL, Sampson EJ, et al. Levels of seven urinary phthalate metabolites in a human reference population. Environ Health Perspect 2000; 108:979-82.
18. Silva MJ, Barr DB, Reidy JA, Malek NA, Hodge CC, Caudill SP, et al. Urinary levels of seven phthalate metabolites in the US population from the National Health and Nutrition Examination Survey (NHANES) 1999-2000. Environ Health Perspect 2004; 112:331-8.
19. David RM, Moore MR, Cifone MA, Finney DC, Guest D. Chronic peroxisome proliferation and hepatomegaly associated with the hepatocellular tumorigenesis of di(2-ethylhexyl)phthalate and the effects of recovery. Toxicol Sci 1999; 50:195-205.
20. Voss C, Zerban H, Bannasch P, Berger MR. Lifelong exposure to di-(2-ethylhexyl)-phthalate induces tumors in liver and testes of Sprague-Dawley rats. Toxicology 2005; 206:359-71.
21. Davis BJ, Maronpot RR, Heindel JJ. Di-(2-ethylhexyl) phthalate suppresses estradiol and ovulation in cycling rats. Toxicol Appl Pharmacol 1994; 128:216-23.
22. Lovekamp-Swan T, Davis BJ. Mechanisms of phthalate ester toxicity in the female reproductive system. Environ Health Perspect 2003; 111:139-45.
23. Parks LG, Ostby JS, Lambright CR, Abbott BD, Klinefelter GR, Barlow NJ, et al. The plasticizer diethylhexyl phthalate induces malformations by decreasing fetal testosterone synthesis during sexual differentiation in the male rat. Toxicol Sci 2000; 58:339-49.
24. Moore RW, Rudy TA, Lin TM, Ko K, Peterson RE. Abnormalities of sexual development in male rats with in utero and lactational exposure to the antiandrogenic plasticizer Di(2-ethylhexyl) phthalate. Environ Health Perspect 2001; 109:229-37.
25. Stroheker T, Cabaton N, Nourdin G, Regnier JF, Lhuguenot JC, Chagnon MC. Evaluation of antiandrogenic activity of di-(2-ethylhexyl)phthalate. Toxicology 2005; 208:115-21.
26. Swan SH, Main KM, Liu F, Stewart SL, Kruse RL, Calafat AM, et al. Decrease in anogenital distance among male infants with prenatal phthalate exposure. Environ Health Perspect 2005; 113:1056-61.
27. Kelce WR, Monosson E, Gamcsik MP, Laws SC, Gray LE Jr. Environmental hormone disruptors: evidence that vinclozolin developmental toxicity is mediated by antiandrogenic metabolites. Toxicol Appl Pharmacol 1994; 126:276-85.
28. Gray LE Jr, Ostby JS, Kelce WR. Developmental effects of an environmental antiandrogen: the fungicide vinclozolin alters sex differentiation of the male rat. Toxicol Appl Pharmacol 1994; 129:46-52.
29. Hellwig J, van Ravenzwaay B, Mayer M, Gembardt C. Pre- and postnatal oral toxicity of vinclozolin in Wistarand Long-Evans rats. Regul Toxicol Pharmacol 2000; 32:42-50.
30. Uzumcu M, Suzuki H, Skinner MK. Effect of the anti-androgenic endocrine disruptor vinclozolin on embryonic testis cord formation and postnatal testis development and function. Reprod Toxicol 2004; 18:765-74.
31. Lane N, Dean W, Erhardt S, Hajkova P, Surani A, Walter J, et al. Resistance of IAPs to methylation reprogramming may provide a mechanism for epigenetic inheritance in the mouse. Genesis 2003; 35:88-93.
32. Rakyan VK, Chong S, Champ ME, Cuthbert PC, Morgan HD, Luu KV, et al. Transgenerational inheritance of epigenetic states at the murine Axin(Fu) allele occurs after maternal and paternal transmission. Proc Natl Acad Sci USA 2003; 100:2538-43.
33. Guerrero-Bosagna C, Settles M, Lucker B, Skinner MK. Epigenetic transgenerational actions of vinclozolin on promoter regions of the sperm epigenome. PLoS One 2010; 5.
34. Stouder C, Paoloni-Giacobino A. Transgenerational effects of the endocrine disruptor vinclozolin on the methylation pattern of imprinted genes in the mouse sperm. Reproduction 2010; 139:373-9.
35. Ferguson-Smith AC, Surani MA. Imprinting and the epigenetic asymmetry between parental genomes. Science 2001; 293:1086-9.
36. Reik W, Walter J. Genomic imprinting: parental influence on the genome. Nat Rev Genet 2001; 2:21-32.
37. Frost JM, Moore GE. The importance of imprinting in the human placenta. PLoS Genet 2010; 6:1001015.
38. Lim AL, Ferguson-Smith AC. Genomic imprinting effects in a compromised in utero environment: implications for a healthy pregnancy. Semin Cell Dev Biol 2010; 21:201-8.
39. Bartolomei MS. Genomic imprinting: employing and avoiding epigenetic processes. Genes Dev 2009; 23:2124-33.
40. Kacem S, Feil R. Chromatin mechanisms in genomic imprinting. Mamm Genome 2009; 20:544-56.
41. Reik W, Dean W, Walter J. Epigenetic reprogramming in mammalian development. Science 2001; 293:1089-93.
42. Mann JR, Szabó PE, Reed MR, Singer-Sam J. Methylated DNA sequences in genomic imprinting. Crit Rev Eukaryot Gene Expr 2000; 10:241-57.
43. Wutz A, Smrzka OW, Schweifer N, Schellander K, Wagner EF, Barlow DP. Imprinted expression of the Igf2r gene depends on an intronic CpG island. Nature 1997; 389:745-9.
44. Thorvaldsen JL, Bartolomei MS. Molecular biology. Mothers setting boundaries. Science 2000; 288:2145-6.
45. Fitzpatrick GV, Soloway PD, Higgins MJ. Regional loss of imprinting and growth deficiency in mice with a targeted deletion of KvDMR1. Nat Genet 2002; 32:426-31.
46. Ferguson-Smith A, Lin SP, Tsai CE, Youngson N, Tevendale M. Genomic imprinting-insights from studies in mice. Semin Cell Dev Biol 2003; 14:43-9.
47. Williamson CM, Turner MD, Ball ST, Nottingham WT, Glenister P, Fray M, et al. Identification of an imprinting control region affecting the expression of all transcripts in the Gnas cluster. Nat Genet 2006; 38:350-5.
48. Li Y, Sasaki H. Genomic imprinting in mammals: its life cycle, molecular mechanisms and reprogramming. Cell Res 2011; 21:466-73.
49. Sasaki H, Matsui Y. Epigenetic events in mammalian germ-cell development: reprogramming and beyond. Nat Rev Genet 2008; 9:129-40.
50. Dolinoy DC, Jirtle RL. Environmental epigenomics in human health and disease. Environ Mol Mutagen 2008; 49:4-8.
51. Jirtle RL, Skinner MK. Environmental epigenomics and disease susceptibility. Nat Rev Genet 2007; 8:253-62.
52. Kato S, Sato T, Watanabe T, Takemasa S, Masuhiro Y, Ohtake F, et al. Function of nuclear sex hormone receptors in gene regulation. Cancer Chemother Pharmacol 2005; 56:4-9.
53. Thorne JL, Campbell MJ, Turner BM. Transcription factors, chromatin and cancer. Int J Biochem Cell Biol 2009; 41:164-75.
54. Dolinoy DC, Huang D, Jirtle RL. Maternal nutrient supplementation counteracts bisphenol A-induced DNA hypomethylation in early development. Proc Natl Acad Sci USA 2007; 104:13056-61.
55. Skinner MK, Manikkam M, Guerrero-Bosagna C. Epigenetic transgenerational actions of endocrine disruptors. Reprod Toxicol 2011; 31:337-43.
56. Clement TM, Savenkova MI, Settles M, Anway MD, Skinner MK. Alterations in the developing testis transcriptome following embryonic vinclozolin exposure. Reprod Toxicol 2010; 30:353-64.
57. Anway MD, Rekow SS, Skinner MK. Transgenerational epigenetic programming of the embryonic testis transcriptome. Genomics 2008; 91:30-40.
58. Imanishi S, Manabe N, Nishizawa H, Morita M, Sugimoto M, Iwahori M, et al. Effects of oral exposure of bisphenol A on mRNA expression of nuclear receptors in murine placentae assessed by DNA microarray. J Reprod Dev 2003; 49:329-36.
59. Nishizawa H, Manabe N, Morita M, Sugimoto M, Imanishi S, Miyamoto H. Effects of in utero exposure to bisphenol A on expression of RARalpha and RXRalpha mRNAs in murine embryos. J Reprod Dev 2003; 49:539-45.
60. Yaoi T, Itoh K, Nakamura K, Ogi H, Fujiwara Y, Fushiki S. Genome-wide analysis of epigenomic alterations in fetal mouse forebrain after exposure to low doses of bisphenol A. Biochem Biophys Res Commun 2008; 376:563-7.
61. Szabó PE, Hubner K, Scholer H, Mann JR. Allelespecific expression of imprinted genes in mouse migratory primordial germ cells. Mech Dev 2002; 115:157-60.
62. Howdeshell KL, Peterman PH, Judy BM, Taylor JA, Orazio CE, Ruhlen RL, et al. Bisphenol A is released from used polycarbonate animal cages into water at room temperature. Environ Health Perspect 2003; 111:1180-7.
63. Seitz H, Youngson N, Lin SP, Dalbert S, Paulsen M, Bachellerie JP, et al. Imprinted microRNA genes transcribed antisense to a reciprocally imprinted retrotransposon-like gene. Nat Genet 2003; 34:261-2.
64. Sekita Y, Wagatsuma H, Nakamura K, Ono R, Kagami M, Wakisaka N, et al. Role of retrotransposon-derived imprinted gene, Rtl1, in the feto-maternal interface of mouse placenta. Nat Genet 2008; 40:243-8.
65. Davis E, Caiment F, Tordoir X, Cavaille J, Ferguson- Smith A, Cockett N, et al. RNAi-mediated allelic trans-interaction at the imprinted Rtl1/Peg11 locus. Curr Biol 2005; 15:743-9.
66. Dolinoy DC, Weinhouse C, Jones TR, Rozek LS, Jirtle RL. Variable histone modifications at the A (vy) metastable epiallele. Epigenetics 2010; 5:637-44.
67. Szabó PE, Mann JR. Biallelic expression of imprinted genes in the mouse germ line: implications for erasure, establishment and mechanisms of genomic imprinting. Genes Dev 1995; 9:1857-68.
68. Szabó PE, Tang SH, Reed MR, Silva FJ, Tsark WM, Mann JR. The chicken beta-globin insulator element conveys chromatin boundary activity but not imprinting at the mouse Igf2/H19 domain. Development 2002; 129:897-904.
69. Haun WJ, Springer NM. Maternal and paternal alleles exhibit differential histone methylation and acetylation at maize imprinted genes. Plant J 2008; 56:903-12.
70. Jurinke C, Denissenko MF, Oeth P, Ehrich M, van den Boom D, Cantor CR. A single nucleotide polymorphism based approach for the identification and characterization of gene expression modulation usingMassARRAY. Mutat Res 2005; 573:83-95.
71. Singh P, Cho J, Tsai SY, Rivas GE, Larson GP, Szabó PE. Coordinated allele-specific histone acetylation at the differentially methylated regions of imprinted genes. Nucleic Acids Res 2010; 38:7974-90.
72. Singh P, Han L, Rivas GE, Lee DH, Nicholson TB, Larson GP, et al. Allele-specific H3K79 Di- versus trimethylation distinguishes opposite parental alleles at imprinted regions. Mol Cell Biol 2010; 30:2693-707.